Ignite Creation Date:
2025-12-17 @ 1:42 PM
Ignite Modification Date:
2025-12-23 @ 4:54 PM
Study NCT ID:
NCT01045161
Status:
COMPLETED
Last Update Posted:
2017-01-23
First Post:
2010-01-07
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-07
First Submit QC Date:
None
Study First Post Date:
2010-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-14
Results First Submit QC Date:
None
Results First Post Date:
2015-12-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-01-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-11-30
Last Update Post Date:
2017-01-23
Last Update Post Date Type:
ESTIMATED